Resmed
ResMed is under Algo Engine buy conditions.

ResMed is under Algo Engine buy conditions.

Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Harvey Norman Holdings buy at the market price with a stop loss at $3.18

The trading update was about resetting the market’s expectations for recovering gross margins.
If CSL trades at 25x FY25 expected earnings the fair value estimate shifts to $320. This is down from previous targets but still highlights the value in buying CSL on any pullback.

The Queen’s Wharf Brisbane’s progressive opening is now expected in April 2024, a four-month delay from the previous opening date in December 2023.
The A$2.9bn development will replace Treasury Casino. From an ownership perspective, Star Ent. has 50% economic interest in Queen’s Wharf Brisbane and will also receive a management fee for operating the integrated resort.
SGR needs to trade through $1.17 to reverse the current negative momentum.

Harvey Norman Holdings buy at the market price with a stop loss at $3.18

The ASX200 Trade Table is up 28.9% year-to-date.


In case you missed it, you can watch last night’s webinar here.
DP:NAS is under Algo Engine buy conditions and the price action is setting up for an entry at $215 with a stop loss at the $201 pivot low.

QCOM:NAS is up 12.1% after 23 days.
